Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cancer Letters|May 15, 2012
Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinomaTerence Kin Wah Lee, Vincent Chi Ho Cheung, Irene Oi Lin Ng
Stem Cells International|March 25, 2017
Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic ImplicationsEunice Yuen-Ting Lau, Nicole Pui-Yu Ho, Terence Kin-Wah Lee
Clinical and Molecular Hepatology|February 5, 2025
Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implicationsHuihai Yang, Martina Mang Leng Lei, Longfei Xie, et al.
Medcomm|July 29, 2025
Polypharmacology-Driven Discovery of ZAK-I-57: A Potent Multi-Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma TherapyShakeel Ahmad Khan, Huihai Yang, Fan Ying, et al.
Cancer Letters|February 14, 2006
FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPaseChun Zhou, Ming-Tat Ling, Terence Kin-Wah Lee, et al.
STAR Protocols|August 18, 2023
Protocol to track the biosynthesis of cholesterol in cultured HCC cells using 13C compound-specific stable isotopic tracersJonathan D Cybulski, Kit Sum Leung, Carmen Oi Ning Leung, et al.
Hepatology (Baltimore, Md.)|October 28, 2010
Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulationTerence Kin Wah Lee, Antonia Castilho, Vincent Chi Ho Cheung, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 12, 2003
Intragraft gene expression profiles by cDNA microarray in small-for-size liver graftsKwan Man, Chung-Mau Lo, Terence Kin-Wah Lee, et al.
Cell Stem Cell|July 6, 2011
CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulationTerence Kin Wah Lee, Antonia Castilho, Vincent Chi Ho Cheung, et al.
Oncology Reports|June 18, 2004
Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinomaTerence Kin-Wah Lee, Kwan Man, Ronnie Tung-Ping Poon, et al.
Pageof 9